CCL22 and neoplasm: Collectively, skewed immune cells such as TAM and Treg, special angiogenic vessels such as tumor-associated endothelial cells, and various proinflammatory cytokines/chemokines including CCL18 and CCL22 are synergistically involved in the suppression of anti-tumor immunity.